KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Acquisitions & Divestments (2016 - 2025)

Novavax (NVAX) has 14 years of Change in Acquisitions & Divestments data on record, last reported at $98.6 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 70.82% year-over-year to $98.6 million; the TTM value through Dec 2025 reached $353.7 million, down 20.25%, while the annual FY2025 figure was $353.7 million, 20.25% down from the prior year.
  • Change in Acquisitions & Divestments reached $98.6 million in Q4 2025 per NVAX's latest filing, down from $100.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $337.9 million in Q4 2024 and bottomed at $2.2 million in Q2 2021.
  • Average Change in Acquisitions & Divestments over 3 years is $119.6 million, with a median of $103.1 million recorded in 2024.
  • Peak YoY movement for Change in Acquisitions & Divestments: crashed 92.44% in 2021, then fell 4.84% in 2025.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $2.2 million in 2021, then soared by 14919.73% to $337.9 million in 2024, then plummeted by 70.82% to $98.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $98.6 million in Q4 2025, $100.5 million in Q3 2025, and $111.6 million in Q2 2025.